Recent studies have shown that ZBTB18 inhibits the expression of PI3K,[12] which plays a role in reducing thyroxine levels and even thyroid cancer.[19] However, there is no relevant research on the activation of PI3K/AKt pathway by ZBTB18 gene mutation leading to thyroid disease. Here, AKT1 is linked to thyroid gland carcinoma.